Sonoma Pharmaceuticals(DE:O8Z)
€2.690.00 (0.00%)
DE:O8Z
Sonoma Pharmaceuticals financials statements
€2.69
At close:0.00 (0.00%)
Sonoma Pharmaceuticals (O8Z) Financial Statements
1 Followers
Sonoma Pharmaceuticals Financial Overview
Sonoma Pharmaceuticals's market cap is currently $4.92M. The company's EPS TTM is $-0.91; its P/E ratio is -1.36; Sonoma Pharmaceuticals has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 19.53M | $ 14.29M | $ 12.73M | $ 13.27M | $ 12.63M |
| Gross Profit | $ 7.42M | $ 5.46M | $ 4.75M | $ 4.48M | $ 3.99M |
| Operating Income | $ -2.46M | $ -3.71M | $ -4.70M | $ -4.57M | $ -5.89M |
| EBITDA | $ -2.32M | $ -2.77M | $ -4.86M | $ -5.06M | $ -5.22M |
| Net Income | $ -3.17M | $ -3.46M | $ -4.83M | $ -5.15M | $ -5.09M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 2.40M | $ 5.37M | $ 3.13M | $ 3.82M | $ 7.40M |
| Total Assets | $ 13.96M | $ 13.69M | $ 14.74M | $ 16.23M | $ 18.84M |
| Total Debt | $ 842.00K | $ 305.00K | $ 608.00K | $ 849.00K | $ 1.37M |
| Net Debt | $ -1.56M | $ -5.07M | $ -2.52M | $ -2.97M | $ -6.03M |
| Total Liabilities | $ 10.87M | $ 9.28M | $ 8.60M | $ 8.25M | $ 10.15M |
| Stockholders' Equity | $ 3.10M | $ 4.41M | $ 6.14M | $ 7.98M | $ 8.70M |
| Cash Flow | |||||
| Free Cash Flow | $ -4.13M | $ -168.00K | $ -2.42M | $ -6.42M | $ -4.38M |
| Operating Cash Flow | $ -3.93M | $ -88.00K | $ -2.40M | $ -6.15M | $ -4.25M |
| Investing Cash Flow | $ -192.00K | $ -80.00K | $ -2.00K | $ -258.00K | $ -99.00K |
| Financing Cash Flow | $ 477.00K | $ 3.03M | $ 1.68M | $ 2.49M | $ 7.40M |
Currency in USD
